ADAGE CAPITAL PARTNERS GP, L.L.C.
Position in TVTX — Travere Therapeutics, Inc.
CIK 1165408
Boston, MA
Position in TVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$145,965,114
+$116,938,444 QoQ
Shares Held
2,569,356
+163.0% QoQ
Ownership
2.73%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#9
of 317 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. TVTX ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
This page
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in TVTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $145,965,114 | 2,569,356 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $29,026,670 | 977,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $111,840,670 | 2,927,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $84,892,800 | 3,552,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $41,203,200 | 2,784,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $39,153,372 | 2,184,898 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,563,856 | 376,800 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,596,000 | 400,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,288,000 | 400,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,855,000 | 500,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,495,000 | 500,000 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $92,523,005 | 4,113,962 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $54,678,000 | 2,600,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $57,904,000 | 2,350,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $47,248,500 | 1,950,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $38,719,218 | 1,502,492 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $40,429,351 | 1,302,492 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $41,225,000 | 1,700,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $52,433,002 | 3,593,763 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $113,613,500 | 4,550,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $77,676,750 | 2,850,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 RTRX | — | 1,534,500 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 RTRX | — | 1,634,500 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 RTRX | — | 1,041,798 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||